Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
14,189,568
-
Share change
-
+741,335
-
Total reported value
-
$81,023,000
-
Price per share
-
$5.71
-
Number of holders
-
40
-
Value change
-
+$2,843,898
-
Number of buys
-
22
-
Number of sells
-
21
Institutional Holders of EPIRUS BIOPHARMACEUTICALS IN - COM (EPRSQ) as of Q2 2015
As of 30 Jun 2015,
EPIRUS BIOPHARMACEUTICALS IN - COM (EPRSQ) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,189,568 shares.
The largest 10 holders included
JENNISON ASSOCIATES LLC, Consonance Capital Management LP, TPG Group Holdings (SBS) Advisors, Inc., Camber Capital Management LLC, FMR LLC, Cormorant Asset Management, LLC, Broadfin Capital, LLC, ADAGE CAPITAL PARTNERS GP LLC, VANGUARD GROUP INC, and BAILARD, INC..
This page lists
40
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.